ABBV-075,
Mivebresib,
ABBV-075,
1445993-26-9,
UNII-VR86R11J7J,
VR86R11J7J,
N-[4-(2,4-Difluorophenoxy)-3-(6-Methyl-7-Oxo-6,7-Dihydro-1h-Pyrrolo[2,3-C]pyridin-4-Yl)phenyl]ethanesulfonamide,
N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide,
8NG,
Ethanesulfonamide, N-(4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo(2,3-C)pyridin-4-yl)phenyl)-,
Ethanesulfonamide, N-[4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]-,
Mivebresib [INN],
Mivebresib [USAN],
mivebresib-abbv-075,
Mivebresib(ABBV-075),
ABBV-075 (Mivebresib),
ABBV075,
GTPL9117,
CHEMBL3987016,
SCHEMBL15068241,
Mivebresib(ABBV-075 pound(c),
RDONXGFGWSSFMY-UHFFFAOYSA-N,
BDBM220447,
BCP18592,
EX-A1082,
MFCD30377200,
s8400,
AKOS030628486,
ZINC146486516,
CS-5815,
SB19768,
Example 36 [WO2013097601],
AC-29897,
AK678629,
HY-100015,
US9296741, 36,
N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro- 1H-pyrrolo(2,3-C)pyridin-4-yl)phenyl)ethanesulfonamide,
N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide,